Market Roles and their Incentives in the Token Cycle

Rejuve is a multi-sided market of data, AI processing, health entrepreneurs, and customer facing health businesses.

Rejuve Entrepreneurs: Support the economy by buying pNFT shards, whose proceeds go reward to data contributors, wearable manufacturers, testing companies, supplement companies and labs. While the network is young and entrepreneurs are few, the Rejuve organization will take the role of the entrepreneur, issuing users and network participants tokens immediately to early data contributors.

Users: add data to our Rejuve app/website through surveys, wearable imports, blood tests, urine tests and DNA tests. A pool of tokens from NFT sales will reward them with every data submission. After a verification process, labs pay users in Rejuve tokens for the use of their data. When labs use their data in support of a product, users also receive newly minted Product NFT tokens, at least half of which they own permanently (the other half may be sold to Rejuve Entrepreneurs). Their value will depend on whether they are associated with products which go to market. With each sale of the final product in tokens, they get a percentage of the tokens that is proportional to the value that their data contributed to it, that they did not sell to entrepreneurs. They thus own a small amount of the product, and the Product NFT keeps track of this. Users use Rejuve tokens to buy wearables, tests, and longevity treatments from network partners. For their contributions to longevity treatment development, users gain enough tokens to receive deep discounts on those and other expensive treatments. The Rejuve NFT sales pool pays users as they go along, in a virtuous cycle – for example, users get paid in tokens for filling out surveys, and use these tokens to buy wearables to submit data, which earns them more tokens that they use to buy DNA test kits so they can provide more data and earn more tokens, etc. User data is securely stored and locked in HIPAA-compliant centralized databases at first, and will be decentralized when practical.

Health industry partners: Wearables, test and supplement suppliers, etc. can take part in the network at constant fiat rates, depending on Rejuve to cover the risk of currency trade fluctuations for a short time. This takes the form of a pool of Rejuve tokens that cover the risk between price settlement and conversion to fiat.

Labs: receive tokens from pharmaceutical companies for their contribution to drug discovery, or entrepreneurs who are willing to wait for such discoveries and buy ownership in the form of Product NFT shards. Labs use tokens to enable drug discovery through the Rejuve AI, and pay users for each use of their data in the app. The labs benefit the supply chain by providing research.

Longevity clinics: receive tokens from pharmaceutical companies for their contribution to drug discovery, or entrepreneurs who are willing to wait for such discoveries and purchase Product NFT shards so the clinics can have tokens up front. Longevity clinics use tokens to recruit patients assistance for Phase 1 clinical trials of new substances (suggested by the AI). They may participate in the network as hybrid entities, being a lab to the extent to which they provide research. They may also purchase supplements and substances from pharmaceutical companies for trials as well as patient treatments.

After regulatory approval and a product launch, pharmaceutical companies pay tokens to users, longevity clinics, labs, and other network participants that have contributed to successful Phase 1 trials. They receive tokens from approved pharmacies that distribute the new products to the token holders for tokens and, after a time, to the public for fiat. They then trade fiat for the NFT owner’s allocation in tokens.

Pharmacies then distribute the end product to network users for tokens, and, if they are approved distributors, also buy the product in tokens to resell and distribute to the general public for fiat, taking their margin. It will be a small margin because the amount of tokens that are allocated to the data owners are negotiated based on the market value of the product outside the network. The allocation is the same for sales inside or outside the network.

Figure 6. The Rejuve Token Cycle